This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Amyotrophic Lateral Sclerosis Market

Market Insights on Amyotrophic Lateral Sclerosis sales outlook, demand forecast & up-to-date key trends

Amyotrophic Lateral Sclerosis Market By Treatment, Distribution Channel & Region – Forecast 2023–2033

Amyotrophic Lateral Sclerosis Market Snapshot (2023-2033)

The global Amyotrophic Lateral Sclerosis market is expected to garner a market value of US$ 743.90 Million in 2023 and is expected to accumulate a market value of US$ 1332.22 Million by registering a CAGR of 6% in the forecast period 2023-2033. Growth of the Amyotrophic Lateral Sclerosis market can be attributed to the rising geriatric population, growing awareness about ALS, and increasing incidence rate. The market for Amyotrophic Lateral Sclerosis registered a CAGR of 4% in the historical period 2017-2022.

Supplemental approvals for existing treatment options are likely to bolster the market growth in future years. In addition to that, many renowned companies are aiming to submit their applications for the approval for new drug therapies, which is another crucial factor that is estimated to aid the growth.

Report Attribute

Details

Expected Market Value (2023)

US$ 743.90 Million

Anticipated Forecast Value (2033)

US$ 1332.22 Million

Projected Growth Rate (2023-2033)

6% CAGR

Customize this Report

Let us know your requirement to get
100% FREE customization

2017-2022 Amyotrophic Lateral Sclerosis Market Demand Analysis vs. Forecast 2023-2033

According to market research and competitive intelligence provider Future Market Insights- the market for Amyotrophic Lateral Sclerosis reflected a value of 4% during the historical period, 2017-2022. National lockdown, government controls, and a spike in infection rates across countries all had a major financial impact on client engagement.

Amyotrophic lateral sclerosis, a progressive neurodegenerative disorder, damages nerve cells in the central nervous system responsible for controlling the voluntary muscles. As per studies, around half of the people suffering from ALS may lose the ability to swallow, breathe, speak, walk, and use their hands. Thus, the market for Amyotrophic Lateral Sclerosis is expected to register a CAGR of 6% in the forecast period 2023-2033.

Which are Some Prominent Drivers of Amyotrophic Lateral Sclerosis Market?

Increasing incidence of cancer to push the market growth

The increasing prevalence of amyotrophic lateral sclerosis disease is one of the biggest drivers of the market. According to the National Institute of Neurological Disorders and Stroke (NINDS), following gradual paralysis, patients with ALS often die from respiratory failure within 3-5 years. It also states that between the two types of ALS, the sporadic type is the most common form, accounting for 90- 95% of all cases in the U.S. while the familial type accounts for the rest.

In addition to this, an inclination of population towards a stationary lifestyle and increasing geriatric population has increased the demand for targeted and indicating treatment options, which are driving the global amyotrophic lateral sclerosis market.

Sabyasachi Ghosh
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What are the Challenges Faced by the Amyotrophic Lateral Sclerosis Market?

Expensive Cost of Treatment to restrict Market Growth

The expensive treatment of Amyotrophic lateral sclerosis, less awareness of amyotrophic lateral sclerosis disease, and insubstantial treatment options are hampering the market growth.

Region-Wise Insights

How is the Market for Amyotrophic Lateral Sclerosis Turning Out in the Asia Pacific Region?

Increased revenue generation propelling growth of Amyotrophic Lateral Sclerosis in Asia Pacific

The Asia Pacific is expected to exhibit the fastest growth rate of all regions over the forecast period, with a CAGR of 5% during the forecast period.

The industry is witnessing an increasing revenue generation in this region, especially in India and China. Major factors propelling the market growth in this region include growing R&D investment in the healthcare sector, plenty of unexplored opportunities, and promising initiatives by the manufacturers as well as the governments.

What are the Factors Boosting the Market for Amyotrophic Lateral Sclerosis in North America?

High Concentration of Key Players shaping landscape for Amyotrophic Lateral Sclerosis in North America

North America is anticipated to acquire a market share of about 20% in the forecast period. This growth is attributable to the availability of recently developed immunosuppressants and the presence of a favorable reimbursement scenario across the U.S.

It is estimated that the high healthcare expenditure along with the huge demand for ALS drugs, and established healthcare infrastructure are the factors driving the market. According to the data published in the Centers for Disease Control and Prevention (CDC) Morbidity and Mortality Weekly Report, in 2015 around 16,583 cases of amyotrophic lateral sclerosis were identified in the U.S. 

Besides, the presence of a large number of significant pharmaceutical companies in the U.S. is set to bode well for the North America market. Thus, given the aforementioned factors, the market is expected to grow significantly over the forecast period in North America.

MarketNage
Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

Category-Wise Insights

Based on Treatment, Which Segment is Pushing the Market Growth?

Superior efficiency of Stem cell therapy bolstering the growth

On the basis of treatment, the segment has been divided into medications, stem cell therapies, and others. Stem cell therapy is expected to show the highest CAGR owing to the increasing demand for new approaches and advanced treatment options. In addition to this, several initiatives have been taken by the government authoritative bodies and the Collaborative ALS Drug Discovery Initiative (CADDI) to fast-track the development of novel drugs and treatments.

By Distribution Channels, Which Segment Dominates the Market?

Hospital pharmacies to drive market growth

The distribution channel segment has been divided into hospital pharmacies, retail pharmacies, and others. According to the FMI analysis, Hospital pharmacies account for the largest market share. The requirement for several hospital stays and visits during ALS treatment facilitates the growth of this segment.

Start-Up in the Amyotrophic Lateral Sclerosis Market

Key start-up players in the Amyotrophic Lateral Sclerosis market are-

  • Since its founding in Tel Aviv in 2017, neurodegenerative disease startup NeuroSense Therapeutics has been eyeing the U.S. market. Now, the company (Nasdaq: NRSN) is using its local headquarters in Cambridge to anchor its efforts to advance a drug that aims to treat amyotrophic lateral sclerosis (ALS).
  • QurAlis has raised seed funding from a syndicate featuring Amgen Ventures. The startup will use the cash to advance treatments for three subtypes of amyotrophic lateral sclerosis (ALS). Amgen joined with MP Healthcare Venture Management and Alexandria Venture Investments to put the latest tranche of funding into QurAlis, which bankrolled its early days using money from friends and family investors. Bringing the new investors on board equips QurAlis to advance programs based on understanding of the genetics and biomarkers associated with different types of ALS.

Market Competition              

Key players in the Amyotrophic Lateral Sclerosis market are Mitsubishi Tanabe Pharma Corporation; Otsuka Pharmaceutical Co., Ltd.; BrainStorm Therapeutics; Biogen Inc.; Corestem; AB Science; F.Hoffmann-La Roche AG; Biohaven Pharmaceutical; Sun Pharmaceutical; and Ionis Pharmaceuticals, Inc.

  • In June 2021, CRISPR Therapeutics and Capsida Biotherapeutics Inc. entered into a strategic partnership to research, develop, manufacture and commercialize in vivo gene editing therapies using CRISPR technology delivered with engineered AAV vectors for the treatment of familial amyotrophic lateral sclerosis (ALS) and Friedreich’s ataxia. Such partnerships are likely to bolster market growth.
  • In June 2022, Canada approved Amylyx Pharmaceuticals Inc.’s new drug ALBRIOZA (also known as AMX0035) for amyotrophic lateral sclerosis.

Report Scope

Report Attribute

Details

Market Value in 2023

US$ 743.90 Million

Market Value in 2033

US$ 1332.22 Million

Growth Rate

CAGR of 6% from 2023 to 2033

Base Year for Estimation

2022

Historical Data

2017-2022

Forecast Period

2023-2033

Quantitative Units

Revenue in USD Million and CAGR from 2023-2033

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis

Segments Covered

  • Treatment
  • Distribution Channel
  • Region

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • MEA

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Argentina
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • Nordics
  • BENELUX
  • Australia & New Zealand
  • China
  • India
  • ASEAN
  • GCC
  • South Africa

Key Companies Profiled

  • Mitsubishi Tanabe Pharma Corporation
  • Otsuka Pharmaceutical Co., Ltd.
  • BrainStorm Therapeutics
  • Biogen Inc.
  • Corestem
  • AB Science
  • F.Hoffmann-La Roche AG
  • Biohaven Pharmaceutical
  • Sun Pharmaceutical
  • Ionis Pharmaceuticals, Inc.

Customization

Available Upon Request

Key Segments Profiled in the Amyotrophic Lateral Sclerosis Industry Survey

Treatment:

  • Medication
  • Stem Cell Therapy
  • Others

Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • MEA

Frequently Asked Questions

From 2017-2022, the Amyotrophic Lateral Sclerosis market grew at CAGR of 4%.

The global Amyotrophic Lateral Sclerosis market is expected to grow with a 6% CAGR during 2023-2033.

As of 2033, the Amyotrophic Lateral Sclerosis market is expected to reach US$ 1332.22 Million

According to the FMI analysis, Hospital pharmacies account for the largest market share.

Stem cell therapy is expected to show the highest CAGR owing to the increasing demand for new approaches.

North America is expected to possess 20% market share for Amyotrophic Lateral Sclerosis market.

The Asia Pacific market is predicted to increase significantly throughout the forecast period, with a CAGR of 5% during the forecast period.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018-2022 and Forecast, 2023-2033

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2018-2022

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2023-2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018-2022 and Forecast 2023-2033, By Treatment

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Treatment, 2018-2022

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Treatment, 2023-2033

        5.3.1. Medication

        5.3.2. Stem Cell Therapy

        5.3.3. Others

    5.4. Y-o-Y Growth Trend Analysis By Treatment, 2018-2022

    5.5. Absolute $ Opportunity Analysis By Treatment, 2023-2033

6. Global Market Analysis 2018-2022 and Forecast 2023-2033, By Distribution Channel

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) Analysis By Distribution Channel, 2018-2022

    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2023-2033

        6.3.1. Hospital Pharmacies

        6.3.2. Retail Pharmacies

        6.3.3. Others

    6.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2018-2022

    6.5. Absolute $ Opportunity Analysis By Distribution Channel, 2023-2033

7. Global Market Analysis 2018-2022 and Forecast 2023-2033, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2018-2022

    7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2023-2033

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Europe

        7.3.4. Asia Pacific

        7.3.5. MEA

    7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2018-2022 and Forecast 2023-2033, By Country

    8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

    8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033

        8.2.1. By Country

            8.2.1.1. U.S.

            8.2.1.2. Canada

        8.2.2. By Treatment

        8.2.3. By Distribution Channel

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Treatment

        8.3.3. By Distribution Channel

    8.4. Key Takeaways

9. Latin America Market Analysis 2018-2022 and Forecast 2023-2033, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Treatment

        9.2.3. By Distribution Channel

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Treatment

        9.3.3. By Distribution Channel

    9.4. Key Takeaways

10. Europe Market Analysis 2018-2022 and Forecast 2023-2033, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. U.K.

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Rest of Europe

        10.2.2. By Treatment

        10.2.3. By Distribution Channel

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Treatment

        10.3.3. By Distribution Channel

    10.4. Key Takeaways

11. Asia Pacific Market Analysis 2018-2022 and Forecast 2023-2033, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033

        11.2.1. By Country

            11.2.1.1. China

            11.2.1.2. Japan

            11.2.1.3. South Korea

            11.2.1.4. Singapore

            11.2.1.5. Thailand

            11.2.1.6. Indonesia

            11.2.1.7. Australia

            11.2.1.8. New Zealand

            11.2.1.9. Rest of Asia Pacific

        11.2.2. By Treatment

        11.2.3. By Distribution Channel

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Treatment

        11.3.3. By Distribution Channel

    11.4. Key Takeaways

12. MEA Market Analysis 2018-2022 and Forecast 2023-2033, By Country

    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022

    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033

        12.2.1. By Country

            12.2.1.1. GCC Countries

            12.2.1.2. South Africa

            12.2.1.3. Israel

            12.2.1.4. Rest of MEA

        12.2.2. By Treatment

        12.2.3. By Distribution Channel

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Treatment

        12.3.3. By Distribution Channel

    12.4. Key Takeaways

13. Key Countries Market Analysis

    13.1. U.S.

        13.1.1. Pricing Analysis

        13.1.2. Market Share Analysis, 2022

            13.1.2.1. By Treatment

            13.1.2.2. By Distribution Channel

    13.2. Canada

        13.2.1. Pricing Analysis

        13.2.2. Market Share Analysis, 2022

            13.2.2.1. By Treatment

            13.2.2.2. By Distribution Channel

    13.3. Brazil

        13.3.1. Pricing Analysis

        13.3.2. Market Share Analysis, 2022

            13.3.2.1. By Treatment

            13.3.2.2. By Distribution Channel

    13.4. Mexico

        13.4.1. Pricing Analysis

        13.4.2. Market Share Analysis, 2022

            13.4.2.1. By Treatment

            13.4.2.2. By Distribution Channel

    13.5. Germany

        13.5.1. Pricing Analysis

        13.5.2. Market Share Analysis, 2022

            13.5.2.1. By Treatment

            13.5.2.2. By Distribution Channel

    13.6. U.K.

        13.6.1. Pricing Analysis

        13.6.2. Market Share Analysis, 2022

            13.6.2.1. By Treatment

            13.6.2.2. By Distribution Channel

    13.7. France

        13.7.1. Pricing Analysis

        13.7.2. Market Share Analysis, 2022

            13.7.2.1. By Treatment

            13.7.2.2. By Distribution Channel

    13.8. Spain

        13.8.1. Pricing Analysis

        13.8.2. Market Share Analysis, 2022

            13.8.2.1. By Treatment

            13.8.2.2. By Distribution Channel

    13.9. Italy

        13.9.1. Pricing Analysis

        13.9.2. Market Share Analysis, 2022

            13.9.2.1. By Treatment

            13.9.2.2. By Distribution Channel

    13.10. China

        13.10.1. Pricing Analysis

        13.10.2. Market Share Analysis, 2022

            13.10.2.1. By Treatment

            13.10.2.2. By Distribution Channel

    13.11. Japan

        13.11.1. Pricing Analysis

        13.11.2. Market Share Analysis, 2022

            13.11.2.1. By Treatment

            13.11.2.2. By Distribution Channel

    13.12. South Korea

        13.12.1. Pricing Analysis

        13.12.2. Market Share Analysis, 2022

            13.12.2.1. By Treatment

            13.12.2.2. By Distribution Channel

    13.13. Singapore

        13.13.1. Pricing Analysis

        13.13.2. Market Share Analysis, 2022

            13.13.2.1. By Treatment

            13.13.2.2. By Distribution Channel

    13.14. Thailand

        13.14.1. Pricing Analysis

        13.14.2. Market Share Analysis, 2022

            13.14.2.1. By Treatment

            13.14.2.2. By Distribution Channel

    13.15. Indonesia

        13.15.1. Pricing Analysis

        13.15.2. Market Share Analysis, 2022

            13.15.2.1. By Treatment

            13.15.2.2. By Distribution Channel

    13.16. Australia

        13.16.1. Pricing Analysis

        13.16.2. Market Share Analysis, 2022

            13.16.2.1. By Treatment

            13.16.2.2. By Distribution Channel

    13.17. New Zealand

        13.17.1. Pricing Analysis

        13.17.2. Market Share Analysis, 2022

            13.17.2.1. By Treatment

            13.17.2.2. By Distribution Channel

    13.18. GCC Countries

        13.18.1. Pricing Analysis

        13.18.2. Market Share Analysis, 2022

            13.18.2.1. By Treatment

            13.18.2.2. By Distribution Channel

    13.19. South Africa

        13.19.1. Pricing Analysis

        13.19.2. Market Share Analysis, 2022

            13.19.2.1. By Treatment

            13.19.2.2. By Distribution Channel

    13.20. Israel

        13.20.1. Pricing Analysis

        13.20.2. Market Share Analysis, 2022

            13.20.2.1. By Treatment

            13.20.2.2. By Distribution Channel

14. Market Structure Analysis

    14.1. Competition Dashboard

    14.2. Competition Benchmarking

    14.3. Market Share Analysis of Top Players

        14.3.1. By Regional

        14.3.2. By Treatment

        14.3.3. By Distribution Channel

15. Competition Analysis

    15.1. Competition Deep Dive

        15.1.1. Mitsubishi Tanabe Pharma Corporation

            15.1.1.1. Overview

            15.1.1.2. Product Portfolio

            15.1.1.3. Profitability by Market Segments

            15.1.1.4. Sales Footprint

            15.1.1.5. Strategy Overview

                15.1.1.5.1. Marketing Strategy

        15.1.2. Otsuka Pharmaceutical Co., Ltd.

            15.1.2.1. Overview

            15.1.2.2. Product Portfolio

            15.1.2.3. Profitability by Market Segments

            15.1.2.4. Sales Footprint

            15.1.2.5. Strategy Overview

                15.1.2.5.1. Marketing Strategy

        15.1.3. BrainStorm Therapeutics

            15.1.3.1. Overview

            15.1.3.2. Product Portfolio

            15.1.3.3. Profitability by Market Segments

            15.1.3.4. Sales Footprint

            15.1.3.5. Strategy Overview

                15.1.3.5.1. Marketing Strategy

        15.1.4. Biogen Inc.

            15.1.4.1. Overview

            15.1.4.2. Product Portfolio

            15.1.4.3. Profitability by Market Segments

            15.1.4.4. Sales Footprint

            15.1.4.5. Strategy Overview

                15.1.4.5.1. Marketing Strategy

        15.1.5. Corestem

            15.1.5.1. Overview

            15.1.5.2. Product Portfolio

            15.1.5.3. Profitability by Market Segments

            15.1.5.4. Sales Footprint

            15.1.5.5. Strategy Overview

                15.1.5.5.1. Marketing Strategy

        15.1.6. AB Science

            15.1.6.1. Overview

            15.1.6.2. Product Portfolio

            15.1.6.3. Profitability by Market Segments

            15.1.6.4. Sales Footprint

            15.1.6.5. Strategy Overview

                15.1.6.5.1. Marketing Strategy

        15.1.7. F.Hoffmann-La Roche AG

            15.1.7.1. Overview

            15.1.7.2. Product Portfolio

            15.1.7.3. Profitability by Market Segments

            15.1.7.4. Sales Footprint

            15.1.7.5. Strategy Overview

                15.1.7.5.1. Marketing Strategy

        15.1.8. Biohaven Pharmaceutical

            15.1.8.1. Overview

            15.1.8.2. Product Portfolio

            15.1.8.3. Profitability by Market Segments

            15.1.8.4. Sales Footprint

            15.1.8.5. Strategy Overview

                15.1.8.5.1. Marketing Strategy

        15.1.9. Sun Pharmaceutical

            15.1.9.1. Overview

            15.1.9.2. Product Portfolio

            15.1.9.3. Profitability by Market Segments

            15.1.9.4. Sales Footprint

            15.1.9.5. Strategy Overview

                15.1.9.5.1. Marketing Strategy

        15.1.10. Ionis Pharmaceuticals, Inc.

            15.1.10.1. Overview

            15.1.10.2. Product Portfolio

            15.1.10.3. Profitability by Market Segments

            15.1.10.4. Sales Footprint

            15.1.10.5. Strategy Overview

                15.1.10.5.1. Marketing Strategy

16. Assumptions & Acronyms Used

17. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Market Value (US$ Mn) Forecast by Region, 2018-2033

Table 2: Global Market Value (US$ Mn) Forecast by Treatment, 2018-2033

Table 3: Global Market Value (US$ Mn) Forecast by Distribution Channel, 2018-2033

Table 4: North America Market Value (US$ Mn) Forecast by Country, 2018-2033

Table 5: North America Market Value (US$ Mn) Forecast by Treatment, 2018-2033

Table 6: North America Market Value (US$ Mn) Forecast by Distribution Channel, 2018-2033

Table 7: Latin America Market Value (US$ Mn) Forecast by Country, 2018-2033

Table 8: Latin America Market Value (US$ Mn) Forecast by Treatment, 2018-2033

Table 9: Latin America Market Value (US$ Mn) Forecast by Distribution Channel, 2018-2033

Table 10: Europe Market Value (US$ Mn) Forecast by Country, 2018-2033

Table 11: Europe Market Value (US$ Mn) Forecast by Treatment, 2018-2033

Table 12: Europe Market Value (US$ Mn) Forecast by Distribution Channel, 2018-2033

Table 13: Asia Pacific Market Value (US$ Mn) Forecast by Country, 2018-2033

Table 14: Asia Pacific Market Value (US$ Mn) Forecast by Treatment, 2018-2033

Table 15: Asia Pacific Market Value (US$ Mn) Forecast by Distribution Channel, 2018-2033

Table 16: MEA Market Value (US$ Mn) Forecast by Country, 2018-2033

Table 17: MEA Market Value (US$ Mn) Forecast by Treatment, 2018-2033

Table 18: MEA Market Value (US$ Mn) Forecast by Distribution Channel, 2018-2033

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Market Value (US$ Mn) by Treatment, 2023-2033

Figure 2: Global Market Value (US$ Mn) by Distribution Channel, 2023-2033

Figure 3: Global Market Value (US$ Mn) by Region, 2023-2033

Figure 4: Global Market Value (US$ Mn) Analysis by Region, 2018-2033

Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2023-2033

Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2023-2033

Figure 7: Global Market Value (US$ Mn) Analysis by Treatment, 2018-2033

Figure 8: Global Market Value Share (%) and BPS Analysis by Treatment, 2023-2033

Figure 9: Global Market Y-o-Y Growth (%) Projections by Treatment, 2023-2033

Figure 10: Global Market Value (US$ Mn) Analysis by Distribution Channel, 2018-2033

Figure 11: Global Market Value Share (%) and BPS Analysis by Distribution Channel, 2023-2033

Figure 12: Global Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023-2033

Figure 13: Global Market Attractiveness by Treatment, 2023-2033

Figure 14: Global Market Attractiveness by Distribution Channel, 2023-2033

Figure 15: Global Market Attractiveness by Region, 2023-2033

Figure 16: North America Market Value (US$ Mn) by Treatment, 2023-2033

Figure 17: North America Market Value (US$ Mn) by Distribution Channel, 2023-2033

Figure 18: North America Market Value (US$ Mn) by Country, 2023-2033

Figure 19: North America Market Value (US$ Mn) Analysis by Country, 2018-2033

Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2023-2033

Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2023-2033

Figure 22: North America Market Value (US$ Mn) Analysis by Treatment, 2018-2033

Figure 23: North America Market Value Share (%) and BPS Analysis by Treatment, 2023-2033

Figure 24: North America Market Y-o-Y Growth (%) Projections by Treatment, 2023-2033

Figure 25: North America Market Value (US$ Mn) Analysis by Distribution Channel, 2018-2033

Figure 26: North America Market Value Share (%) and BPS Analysis by Distribution Channel, 2023-2033

Figure 27: North America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023-2033

Figure 28: North America Market Attractiveness by Treatment, 2023-2033

Figure 29: North America Market Attractiveness by Distribution Channel, 2023-2033

Figure 30: North America Market Attractiveness by Country, 2023-2033

Figure 31: Latin America Market Value (US$ Mn) by Treatment, 2023-2033

Figure 32: Latin America Market Value (US$ Mn) by Distribution Channel, 2023-2033

Figure 33: Latin America Market Value (US$ Mn) by Country, 2023-2033

Figure 34: Latin America Market Value (US$ Mn) Analysis by Country, 2018-2033

Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2023-2033

Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023-2033

Figure 37: Latin America Market Value (US$ Mn) Analysis by Treatment, 2018-2033

Figure 38: Latin America Market Value Share (%) and BPS Analysis by Treatment, 2023-2033

Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Treatment, 2023-2033

Figure 40: Latin America Market Value (US$ Mn) Analysis by Distribution Channel, 2018-2033

Figure 41: Latin America Market Value Share (%) and BPS Analysis by Distribution Channel, 2023-2033

Figure 42: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023-2033

Figure 43: Latin America Market Attractiveness by Treatment, 2023-2033

Figure 44: Latin America Market Attractiveness by Distribution Channel, 2023-2033

Figure 45: Latin America Market Attractiveness by Country, 2023-2033

Figure 46: Europe Market Value (US$ Mn) by Treatment, 2023-2033

Figure 47: Europe Market Value (US$ Mn) by Distribution Channel, 2023-2033

Figure 48: Europe Market Value (US$ Mn) by Country, 2023-2033

Figure 49: Europe Market Value (US$ Mn) Analysis by Country, 2018-2033

Figure 50: Europe Market Value Share (%) and BPS Analysis by Country, 2023-2033

Figure 51: Europe Market Y-o-Y Growth (%) Projections by Country, 2023-2033

Figure 52: Europe Market Value (US$ Mn) Analysis by Treatment, 2018-2033

Figure 53: Europe Market Value Share (%) and BPS Analysis by Treatment, 2023-2033

Figure 54: Europe Market Y-o-Y Growth (%) Projections by Treatment, 2023-2033

Figure 55: Europe Market Value (US$ Mn) Analysis by Distribution Channel, 2018-2033

Figure 56: Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2023-2033

Figure 57: Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023-2033

Figure 58: Europe Market Attractiveness by Treatment, 2023-2033

Figure 59: Europe Market Attractiveness by Distribution Channel, 2023-2033

Figure 60: Europe Market Attractiveness by Country, 2023-2033

Figure 61: Asia Pacific Market Value (US$ Mn) by Treatment, 2023-2033

Figure 62: Asia Pacific Market Value (US$ Mn) by Distribution Channel, 2023-2033

Figure 63: Asia Pacific Market Value (US$ Mn) by Country, 2023-2033

Figure 64: Asia Pacific Market Value (US$ Mn) Analysis by Country, 2018-2033

Figure 65: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2023-2033

Figure 66: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2023-2033

Figure 67: Asia Pacific Market Value (US$ Mn) Analysis by Treatment, 2018-2033

Figure 68: Asia Pacific Market Value Share (%) and BPS Analysis by Treatment, 2023-2033

Figure 69: Asia Pacific Market Y-o-Y Growth (%) Projections by Treatment, 2023-2033

Figure 70: Asia Pacific Market Value (US$ Mn) Analysis by Distribution Channel, 2018-2033

Figure 71: Asia Pacific Market Value Share (%) and BPS Analysis by Distribution Channel, 2023-2033

Figure 72: Asia Pacific Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023-2033

Figure 73: Asia Pacific Market Attractiveness by Treatment, 2023-2033

Figure 74: Asia Pacific Market Attractiveness by Distribution Channel, 2023-2033

Figure 75: Asia Pacific Market Attractiveness by Country, 2023-2033

Figure 76: MEA Market Value (US$ Mn) by Treatment, 2023-2033

Figure 77: MEA Market Value (US$ Mn) by Distribution Channel, 2023-2033

Figure 78: MEA Market Value (US$ Mn) by Country, 2023-2033

Figure 79: MEA Market Value (US$ Mn) Analysis by Country, 2018-2033

Figure 80: MEA Market Value Share (%) and BPS Analysis by Country, 2023-2033

Figure 81: MEA Market Y-o-Y Growth (%) Projections by Country, 2023-2033

Figure 82: MEA Market Value (US$ Mn) Analysis by Treatment, 2018-2033

Figure 83: MEA Market Value Share (%) and BPS Analysis by Treatment, 2023-2033

Figure 84: MEA Market Y-o-Y Growth (%) Projections by Treatment, 2023-2033

Figure 85: MEA Market Value (US$ Mn) Analysis by Distribution Channel, 2018-2033

Figure 86: MEA Market Value Share (%) and BPS Analysis by Distribution Channel, 2023-2033

Figure 87: MEA Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023-2033

Figure 88: MEA Market Attractiveness by Treatment, 2023-2033

Figure 89: MEA Market Attractiveness by Distribution Channel, 2023-2033

Figure 90: MEA Market Attractiveness by Country, 2023-2033

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Rare Disease Gene Therapy Market

Published : October 2020

Healthcare

Systemic Sclerosis Treatment Market

Published : April 2019

Healthcare

Rare Neurological Disease Treatment Market

Published : March 2018

Healthcare

Atherosclerosis Market

Published : December 2016

Google translate

Amyotrophic Lateral Sclerosis Market